News
Discover the latest news and developments in AI and machine learning happening in the image-guided therapy (IGT) sector in Canada.
A trailblazer in medical imaging: Terry Peters
Terry Peters, a New Zealander-Canadian with a background in Electrical Engineering from the University of Canterbury, has been on a transformative journey in image-guided therapy over his fifty-year career. His story unfolds as a series of pivotal moments and breakthroughs. In 1971, Peters’ mentor Richard Bates redirected his career from engineering to medical imaging. At the time, medical imaging primarily relied on radiographs that had remained unchanged for over 75 years. Peters was tasked with measuring bone density and studying wave scattering in homogeneous mediums. This challenge set the stage for his groundbreaking work discovering computerized tomography (CT). Although his…
INOVAIT and the Government of Canada announce the latest recipients of the INOVAIT Pilot Fund for advancements in image-guided therapy and artificial intelligence
INOVAIT, the pan-Canadian innovation network supporting advancements and commercialization in image-guided therapy (IGT) and artificial intelligence (AI), is excited to announce the latest recipients of its Pilot Fund. This competitive funding program is awarded to compelling medical technology projects that harness the transformative power of AI, machine learning, and big data analytics in IGT to advance medical innovation and streamline care.
INOVAIT announces the release of its impactful new progress report on advancing Canada’s image-guided therapy sector through artificial intelligence
Network News
INOVAIT awards two leading companies and one academic partner for transforming Canada’s healthcare ecosystem
TORONTO, April 25, 2024 /CNW/ - INOVAIT, the national network for commercializing breakthroughs in image-guided...
2024 Discovery Forum Recap
Last week, we hosted our 3rd annual Discovery Forum and welcomed our esteemed members from across the country to Torys...
Tenomix secures oversubscribed $2.1M, all-Canadian financing round to advance cancer staging
Tenomix, an image-guided diagnostic company based out of Western University’s BioNext Medtech Incubator, recently celebrated a significant milestone with an oversubscribed all-Canadian $2.14M funding round. Established in 2021 by four alums of WORLDiscoveries’ Medical Innovation Fellowship program at Western University, Tenomix is transforming cancer staging, particularly in colorectal cancer, with its innovative approach.
PulseMedica is laser-focused on tackling vitreoretinal diseases
The PulseMedica platform is a 3D image-guided therapy device that integrates powerful laser therapy, advanced medical imaging, and limitless machine learning (ML) for precision imaging and treatment of vitreoretinal disease. Vitreoretinal diseases exist within the clear gel (vitreous fluid) that fills the eye and retina at the back of the eye. PulseMedica’s device strives to automate the imaging and treatment process, enabling quick and precise disease targeting, thereby reducing the treatment time and reducing the risk of side effects and total time per patient, allowing for more patients to be treated each day.
IGT Lecture Series
Regulating AI in Image-Guided Therapy
Follow INOVAIT on Social Media
The Network in the Press
